Financials

  • Market Capitalization 277.09 M
  • Employee 34
  • Founded 2004
  • CEO Christopher U. Missling Ph.D.
  • Website www.anavex.com
  • Headquarter New York, United States
  • FIGI BBG000C9K8K4
  • Industry Biotechnology
Total revenue
Net income
Basic earnings per share (Basic EPS)
Total debt
Free cash flow
Cash & equivalents
Price to earnings ratio
-16.48
Price to sales ratio
151.51

Related tickers

#NamePrice24h %7d %1M %1Y %Market CapLast 7 Days
3367
LCTX
Lineage Cell Therapeutics, Inc. Common Stock
1.12 USD-4.27%+3.70%+5.66%-34.77%283.26 M USD
3369
IVVD
Invivyd, Inc. - Common Stock
0.96 USD+6.67%-1.03%+71.43%0.00%282.97 M USD
3397
ALXO
ALX Oncology Holdings Inc. - Common Stock
2.00 USD-2.44%-1.48%+3.09%+76.99%276.55 M USD
3411
TRDA
Entrada Therapeutics, Inc. - Common Stock
7.00 USD-3.71%-7.65%+6.87%+0.43%272.56 M USD

Frequently asked questions about Anavex Life Sciences

What is the Anavex Life Sciences stock price today?

The current price of Anavex Life Sciences (AVXL) is 2.99. Over the past 24 hours, the stock has changed by -4.47%. Follow the AVXL chart for real-time price dynamics.

What is the stock ticker of Anavex Life Sciences?

Anavex Life Sciences trades under the ticker AVXL. Tickers can differ by exchange, so always check the exchange and instrument details before trading.

Is Anavex Life Sciences stock going up?

AVXL has changed by -7.14% over the last week, +19.12% over the last month, and -68.66% over the last year. Review the chart to see whether the current move is part of a broader trend.

What is the market capitalization of Anavex Life Sciences?

Anavex Life Sciences currently has a market capitalization of 277.09 M. Market capitalization reflects the total market value of a company's outstanding shares and is commonly used to compare companies by size.

What were Anavex Life Sciences earnings last quarter?

Last quarter, Anavex Life Sciences reported earnings of -0.06 per share. Earnings per share is one of the key metrics investors use to evaluate a company's profitability and financial performance.

What was Anavex Life Sciences revenue for the last quarter?

Anavex Life Sciences reported quarterly revenue of 1.09 M. Revenue is one of the main indicators used to evaluate the company's business growth and operating scale.

What was Anavex Life Sciences net income for the last quarter?

Anavex Life Sciences reported net income of -5.68 M for the last quarter. The previous quarter showed -9.83 M, which means net income changed by +42.19%.

How many employees does Anavex Life Sciences have?

As of the latest available data, Anavex Life Sciences has 34 employees. Workforce size can provide additional context about the company's scale and operations.

How can I buy Anavex Life Sciences stock?

You can buy Anavex Life Sciences (AVXL) through a broker that provides access to the relevant stock exchange. Before trading, check commissions, execution conditions, account type, and whether the stock fits your investment plan.

Should I invest in Anavex Life Sciences stock?

Investing in Anavex Life Sciences requires reviewing its financial statements, valuation, earnings outlook, news, technical picture, and market risks. Use the AVXL chart and related analysis on metatrader.com as part of your research.

News